FREE SHIPPING ON ORDERS OVER $150

glp-1 for iih Treatment with receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain NeuroOp Guru: Stopping GLP-1 therapy

$20.17

Quantity
- +
Description

9:e97554

glp-1 for iih Treatment with receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain NeuroOp Guru: Stopping GLP-1 therapy

doi: 10.1016/j.neuroscience.2015.05.023 29 RojasMChavez-CastilloMBautistaJOrtegaANavaMSalazarJet al

glp-1 for iih Treatment with receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain NeuroOp Guru: Stopping GLP-1 therapy

A 2025 meta-analysis by South Valley University found a similar pattern when it pooled the Yale trial with 2 others

glp-1 for iih Treatment with receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain NeuroOp Guru: Stopping GLP-1 therapy

S., Al-Kuraishy, H

glp-1 for iih Treatment with receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain NeuroOp Guru: Stopping GLP-1 therapy

You may also like

recommand products